![Applied Therapeutics, Inc. logo](/logos/APLT.webp)
Applied Therapeutics, Inc.
NASDAQ:APLT
Overview | Financials
Company Name | Applied Therapeutics, Inc. |
Symbol | APLT |
Currency | USD |
Price | 5.7 |
Market Cap | 654,622,200 |
Dividend Yield | 0% |
52-week-range | 1.5 - 9.39 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Shoshana Shendelman Ph.D. |
Website | https://www.appliedtherapeutics.com |
An error occurred while fetching data.
About Applied Therapeutics, Inc.
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD